Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test [Yahoo! Finance]
Caris Life Sciences, Inc. (CAI)
Last caris life sciences, inc. earnings: 10/29 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.capps.com/investor-relations
Company Research
Source: Yahoo! Finance
Caris Life Sciences, Inc. (NASDAQ:CAI) is a biotech company that is driven by its breakthroughs in precision oncology, expansion of AI-powered molecular diagnostics, and recent FDA approvals. A pivotal development came with the FDA approval of Caris's MI Cancer Seek platform, the first diagnostic to combine whole exome and whole transcriptome sequencing on a single test for both adult and pediatric tumors. Validated for eight companion diagnostics, including a pan-cancer indication, the platform enables oncologists to comprehensively profile tumors from minimal samples, improving accuracy, access, and turnaround time. This marks a major step toward setting new standards in precision oncology workflows. Beyond tissue-based testing, Caris Life Sciences, Inc. (NASDAQ:CAI) is advancing blood-based diagnostics with Caris Assure, which applies AI to DNA and RNA sequencing for noninvasive early detection and therapy monitoring. The business continues to expand collaborations, such as it
Show less
Read more
Impact Snapshot
Event Time:
CAI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAI alerts
High impacting Caris Life Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
CAI
News
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]Yahoo! Finance
- Caris Life Sciences to Showcase 19 Studies at the 2025 San Antonio Breast Cancer SymposiumPR Newswire
- The Caris Precision Oncology Alliance Welcomes UAMS Winthrop P. Rockefeller Cancer InstitutePR Newswire
- Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class [Yahoo! Finance]Yahoo! Finance
- Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 ClassPR Newswire
CAI
Earnings
- 11/5/25 - Beat
CAI
Sec Filings
- 11/10/25 - Form 4
- 11/10/25 - Form 4
- 11/5/25 - Form 10-Q
- CAI's page on the SEC website